I would be pleasantly surprised if there is news before oppies expiry but I really don't expect it - I'm afraid it's now a waiting game. I also expect that oppies will be rolled over if they aren't in the money. The precedent has been set from last time and if they change this it will leave a very sour taste in the mouth of all oppies holders - myself included.
I still cant't believe that we have a mkt cap less than $18M when the Ph3 trials have been completed - surely there is no other Co. on the ASX in this position.
Anyway, it's now a waiting game and I remain happy to hold. The EMS fiscal cliff is still there but I expect that the cliff edge is Q2 next year. The next quarterly will be important
EMS Price at posting:
3.0¢ Sentiment: Hold Disclosure: Held
